目次

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Women’s Health Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Heightened Attention Towards Emerging Economies
3.2.1.2 Escalated Innovation Targeting New Therapeutic Solutions
3.2.1.3 Expanded Investments in Technology to Enhance Patient Satisfaction
3.2.2 Market Restraining Factors
3.2.2.1 Elevated Pricing Poses a Constraint on Market Expansion
3.2.2.2 Increased Collaboration for the Development of Advanced Healthcare Infrastructure
3.2.3 Market Opportunities
3.2.3.1 Expansion of Preventative Care Services Tailored to Women's Unique Health Needs.
3.2.3.2 Improving Digital Health Platforms to Enhance the Access to Healthcare Services for Women, Particularly in Underserved Areas.
3.2.3.3 Technological Advancements in Reproductive Health Services, Including Family Planning, Fertility Management, and Maternal Care
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Women’s Health Market Analysis by Application
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 Women’s Health Market Size Estimation and Forecast by Application
4.4 Contraceptives
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Postmenopausal Osteoporosis
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Hormonal Infertility
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Menopause
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Polycystic Ovary Syndrome
4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Endometriosis and Uterine Fibroids
4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Others
4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
4.10.2 Market Share by Region, 2024 & 2034 (%)

5 Women’s Health Market Analysis by Distribution Channel
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Women’s Health Market Size Estimation and Forecast by Distribution Channel
5.4 Hospital Pharmacies
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Retail Pharmacies
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Online Pharmacies
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Women’s Health Market Analysis by Drugs
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 Women’s Health Market Size Estimation and Forecast by Drugs
6.4 Xgeva
6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Prolia
6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Mirena
6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Nexplanon
6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Forteo
6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Nuvaring
6.9.1 Market Size by Region, 2024-2034 (US$ Billion)
6.9.2 Market Share by Region, 2024 & 2034 (%)
6.10 Premarin
6.10.1 Market Size by Region, 2024-2034 (US$ Billion)
6.10.2 Market Share by Region, 2024 & 2034 (%)
6.11 Lupron
6.11.1 Market Size by Region, 2024-2034 (US$ Billion)
6.11.2 Market Share by Region, 2024 & 2034 (%)
6.12 Lo Loestrin
6.12.1 Market Size by Region, 2024-2034 (US$ Billion)
6.12.2 Market Share by Region, 2024 & 2034 (%)
6.13 Orilissa/Oriahnn
6.13.1 Market Size by Region, 2024-2034 (US$ Billion)
6.13.2 Market Share by Region, 2024 & 2034 (%)
6.14 Others
6.14.1 Market Size by Region, 2024-2034 (US$ Billion)
6.14.2 Market Share by Region, 2024 & 2034 (%)

7 Women’s Health Market Analysis by Type
7.1 Key Findings
7.2 Application Segment: Market Attractiveness Index
7.3 Women’s Health Market Size Estimation and Forecast by Type
7.4 Generic
7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Branded
7.5.1 Market Size by Region, 2024-2034 (US$ Billion)
7.5.2 Market Share by Region, 2024 & 2034 (%)

8 Women’s Health Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Women’s Health Market Analysis
9.1 Key Findings
9.2 North America Women’s Health Market Attractiveness Index
9.3 North America Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 North America Women’s Health Market Size Estimation and Forecast by Country
9.5 North America Women’s Health Market Size Estimation and Forecast by Application
9.6 North America Women’s Health Market Size Estimation and Forecast by Distribution Channel
9.7 North America Women’s Health Market Size Estimation and Forecast by Drugs
9.8 North America Women’s Health Market Size Estimation and Forecast by Type
9.9 U.S. Women’s Health Market Analysis
9.10 Canada Women’s Health Market Analysis

10 Europe Women’s Health Market Analysis
10.1 Key Findings
10.2 Europe Women’s Health Market Attractiveness Index
10.3 Europe Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Europe Women’s Health Market Size Estimation and Forecast by Country
10.5 Europe Women’s Health Market Size Estimation and Forecast by Application
10.6 Europe Women’s Health Market Size Estimation and Forecast by Distribution Channel
10.7 Europe Women’s Health Market Size Estimation and Forecast by Drugs
10.8 Europe Women’s Health Market Size Estimation and Forecast by Type
10.9 Germany Women’s Health Market Analysis
10.10 France Women’s Health Market Analysis
10.11 UK Women’s Health Market Analysis
10.12 Italy Women’s Health Market Analysis
10.13 Spain Women’s Health Market Analysis
10.14 Russia Women’s Health Market Analysis
10.15 Poland Women’s Health Market Analysis
10.16 Belgium Women’s Health Market Analysis
10.17 Rest of Europe Women’s Health Market Analysis

11 Asia Pacific Women’s Health Market Analysis
11.1 Key Findings
11.2 Asia Pacific Women’s Health Market Attractiveness Index
11.3 Asia Pacific Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Asia Pacific Women’s Health Market Size Estimation and Forecast by Country
11.5 Asia Pacific Women’s Health Market Size Estimation and Forecast by Application
11.6 Asia Pacific Women’s Health Market Size Estimation and Forecast by Distribution Channel
11.7 Asia Pacific Women’s Health Market Size Estimation and Forecast by Drugs
11.8 Asia Pacific Women’s Health Market Size Estimation and Forecast by Type
11.9 Japan Women’s Health Market Analysis
11.10 China Women’s Health Market Analysis
11.11 India Women’s Health Market Analysis
11.12 Australia Women’s Health Market Analysis
11.13 South Korea Women’s Health Market Analysis
11.14 Singapore Women’s Health Market Analysis
11.15 Taiwan Women’s Health Market Analysis
11.16 Rest of Asia Pacific Women’s Health Market Analysis

12 Latin America Women’s Health Market Analysis
12.1 Key Findings
12.2 Latin America Women’s Health Market Attractiveness Index
12.3 Latin America Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 Latin America Women’s Health Market Size Estimation and Forecast by Country
12.5 Latin America Women’s Health Market Size Estimation and Forecast by Application
12.6 Latin America Women’s Health Market Size Estimation and Forecast by Distribution Channel
12.7 Latin America Women’s Health Market Size Estimation and Forecast by Drugs
12.8 Latin America Women’s Health Market Size Estimation and Forecast by Type
12.9 Brazil Women’s Health Market Analysis
12.10 Mexico Women’s Health Market Analysis
12.11 Argentina Women’s Health Market Analysis
12.12 Colombia Women’s Health Market Analysis
12.13 Rest of Latin America Women’s Health Market Analysis

13 MEA Women’s Health Market Analysis
13.1 Key Findings
13.2 MEA Women’s Health Market Attractiveness Index
13.3 MEA Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
13.4 MEA Women’s Health Market Size Estimation and Forecast by Country
13.5 MEA Women’s Health Market Size Estimation and Forecast by Application
13.6 MEA Women’s Health Market Size Estimation and Forecast by Distribution Channel
13.7 MEA Women’s Health Market Size Estimation and Forecast by Drugs
13.8 MEA Women’s Health Market Size Estimation and Forecast by Type
13.9 GCC Women’s Health Market Analysis
13.10 South Africa Women’s Health Market Analysis
13.11 Rest of MEA Women’s Health Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Summary of all Strategic Outlook
14.3 Abbott Laboratories
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 R&D, 2017-2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Bayer AG
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2022
14.4.3.2 R&D, 2017-2022
14.4.3.3 Regional Market Shares, 2022
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Caldera Medical Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product Benchmarking
14.5.4 Strategic Outlook
14.6 Cardinal Health
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2023
14.6.3.2 Regional Market Shares, 2023
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Carestream Health
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Product Benchmarking
14.7.4 Strategic Outlook
14.8 Cooper Surgical Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2023
14.8.3.2 R&D, 2017-2023
14.8.3.3 Regional Market Shares, 2023
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 L. Hoffman-La Roche Ltd.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2023
14.9.3.2 R&D, 2017-2023
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 General Electric Healthcare
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2017-2022
14.10.3.2 R&D, 2017-2022
14.10.3.3 Regional Market Shares, 2022
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Hologic Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2017-2023
14.11.3.2 R&D, 2017-2023
14.11.3.3 Regional Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 koninklijke philips n.v
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2017-2022
14.12.3.2 R&D, 2017-2022
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 MedGyn Products Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 Medline Industries, Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Prestige Consumer Healthcare Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2017-2022
14.15.4 Product Benchmarking
14.16 Siemens AG
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2017-2023
14.16.3.2 R&D, 2017-2023
14.16.3.3 Regional Market Shares, 2023
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Women’s Health Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 7 Contraceptives Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 8 Postmenopausal Osteoporosis Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 9 Hormonal Infertility Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Menopause Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Polycystic Ovary Syndrome Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Endometriosis and Uterine Fibroids Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 15 Hospital Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 16 Retail Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 17 Online Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 Women’s Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 19 Xgeva Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Prolia Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Mirena Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Nexplanon Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Forteo Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Nuvaring Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Premarin Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Lupron Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Lo Loestrin Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 Orilissa/Oriahnn Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Generic Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 Branded Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 34 North America Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 35 North America Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 36 North America Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 37 North America Women’s Health Market Drugs, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 North America Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 U.S. Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Canada Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 41 Europe Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Europe Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 43 Europe Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 44 Europe Women’s Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 45 Europe Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Germany Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 47 France Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 48 UK Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 Italy Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 50 Spain Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 Russia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Poland Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Belgium Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of Europe Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Asia Pacific Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 57 Asia Pacific Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 58 Asia Pacific Women’s Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 59 Asia Pacific Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Japan Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 China Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 India Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 63 Australia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 64 South Korea Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 65 Singapore Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 Taiwan Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 Rest of Asia Pacific Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 68 Latin America Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 Latin America Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 70 Latin America Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 71 Latin America Women’s Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 72 Latin America Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 73 Brazil Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 74 Mexico Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 75 Argentina Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 76 Colombia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 77 Rest of Latin America Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 78 MEA Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 79 MEA Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 80 MEA Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 81 MEA Women’s Health Market by Drugs, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 82 MEA Women’s Health Market by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 83 GCC Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 84 South Africa Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 85 Rest of MEA Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 86 Strategic Outlook
Table 87 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Abbott Laboratories: Product Benchmarking
Table 89 Abbott Laboratories: Strategic Outlook
Table 90 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Bayer AG: Product Benchmarking
Table 92 Bayer AG: Strategic Outlook
Table 93 Caldera Medical Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Caldera Medical Inc: Product Benchmarking
Table 95 Caldera Medical Inc: Strategic Outlook
Table 96 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Cardinal Health: Product Benchmarking
Table 98 Cardinal Health: Strategic Outlook
Table 99 Carestream health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Carestream Health: Product Benchmarking
Table 101 Carestream Health: Strategic Outlook
Table 102 Cooper Surgical Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Cooper Surgical, Inc.: Product Benchmarking
Table 104 Cooper Surgical, Inc.: Strategic Outlook
Table 105 L. Hoffman-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 L. Hoffman-La Roche Ltd.: Product Benchmarking
Table 107 Debiotech SA: Strategic Outlook
Table 108 General Electric Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 General Electric Healthcare: Product Benchmarking
Table 110 General Electric Healthcare: Strategic Outlook
Table 111 Hologic Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Hologic Inc: Product Benchmarking
Table 113 Hologic Inc.: Strategic Outlook
Table 114 koninklijke philips n.v: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Koninklijke Philips N.V: Product Benchmarking
Table 116 Koninklijke Philips N.V: Strategic Outlook
Table 117 MedGyn Products Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 MedGyn Products, Inc.: Product Benchmarking
Table 119 Medline Industries, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Medline Industries Inc: Product Benchmarking
Table 121 Prestige Consumer Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Prestige Consumer Healthcare Inc.: Product Benchmarking
Table 123 Siemens AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Siemens AG: Product Benchmarking
Table 125 Siemens AG: Strategic Outlook
?

List of Figures
Figure 1 Women’s Health Market Segmentation
Figure 2 Women’s Health Market by Application: Market Attractiveness Index
Figure 3 Women’s Health Market by Distribution Channel: Market Attractiveness Index
Figure 4 Women’s Health Market by Drugs: Market Attractiveness Index
Figure 5 Women’s Health Market by Type: Market Attractiveness Index
Figure 6 Women’s Health Market Attractiveness Index by Region
Figure 7 Women’s Health Market: Market Dynamics
Figure 8 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 9 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 10 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 11 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 12 Women’s Health Market: Porter’s Five Forces Analysis
Figure 13 Women’s Health Market: PEST Analysis
Figure 14 Women’s Health Market by Application: Market Attractiveness Index
Figure 15 Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 16 Women’s Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 17 Contraceptives Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Contraceptives Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Postmenopausal Osteoporosis Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Postmenopausal Osteoporosis Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Hormonal Infertility Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Hormonal Infertility Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Menopause Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Menopause Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Polycystic Ovary Syndrome Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Polycystic Ovary Syndrome Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Endometriosis and Uterine Fibroids Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 28 Endometriosis and Uterine Fibroids Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Women’s Health Market by Distribution Channel: Market Attractiveness Index
Figure 32 Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 33 Women’s Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 34 Hospital Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 35 Hospital Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Retail Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 37 Retail Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Online Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 39 Online Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 Women’s Health Market by Drugs: Market Attractiveness Index
Figure 41 Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 42 Women’s Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 43 Xgeva Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 44 Xgeva Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Prolia Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 46 Prolia Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Mirena Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 48 Mirena Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Nexplanon Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 50 Nexplanon Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Forteo Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 52 Forteo Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Nuvaring Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 54 Nuvaring Market Share Forecast by Region, 2024 & 2034 (%)
Figure 55 Premarin Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 56 Premarin Market Share Forecast by Region, 2024 & 2034 (%)
Figure 57 Lupron Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 58 Lupron Market Share Forecast by Region, 2024 & 2034 (%)
Figure 59 Lo Loestrin Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 60 Lo Loestrin Market Share Forecast by Region, 2024 & 2034 (%)
Figure 61 Orilissa/Oriahnn Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 62 Orilissa/Oriahnn Market Share Forecast by Region, 2024 & 2034 (%)
Figure 63 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 64 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 65 Women’s Health Market by Type: Market Attractiveness Index
Figure 66 Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 67 Women’s Health Market Share Forecast by Type 2024, 2029, 2034 (%)
Figure 68 Generic Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 69 Generic Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 70 Branded Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 71 Branded Market Share Forecast by Region, 2024 & 2034 (%)
Figure 72 Women’s Health Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
Figure 73 Women’s Health Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 74 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 75 North America Women’s Health Market Attractiveness Index
Figure 76 North America Women’s Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 77 North America Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 78 North America Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 79 North America Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 80 North America Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 81 North America Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 82 North America Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 83 North America Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 84 North America Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 85 North America Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 86 North America Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 87 U.S. Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 88 Canada Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 89 Europe Women’s Health Market Attractiveness Index
Figure 90 Europe Women’s Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 91 Europe Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 92 Europe Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 93 Europe Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 94 Europe Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 95 Europe Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 96 Europe Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 97 Europe Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 98 Europe Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 99 Europe Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 100 Europe Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 101 Germany Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 102 France Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 103 UK Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 Italy Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 Spain Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 106 Russia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 107 Poland Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 108 Belgium Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Rest of Europe Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Asia Pacific Women’s Health Market Attractiveness Index
Figure 111 Asia Pacific Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
Figure 112 Asia Pacific Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 113 Asia Pacific Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 114 Asia Pacific Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 115 Asia Pacific Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 116 Asia Pacific Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 117 Asia Pacific Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 118 Asia Pacific Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 119 Asia Pacific Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 120 Asia Pacific Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 121 Asia Pacific Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 122 Japan Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 123 China Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 India Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 125 Australia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 126 South Korea Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 127 Singapore Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 128 Taiwan Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 129 Rest of Asia Pacific Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 130 Latin America Women’s Health Market Attractiveness Index
Figure 131 Latin America Women’s Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 132 Latin America Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 133 Latin America Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 134 Latin America Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 135 Latin America Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 136 Latin America Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 137 Latin America Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 138 Latin America Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 139 Latin America Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 140 Latin America Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 141 Latin America Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 142 Brazil Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 143 Mexico Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 144 Argentina Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 145 Colombia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 146 Rest of Latin America Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 147 MEA Women’s Health Market Attractiveness Index
Figure 148 MEA Women’s Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 149 MEA Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 150 MEA Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 151 MEA Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 152 MEA Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 153 MEA Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 154 MEA Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 155 MEA Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 156 MEA Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 157 MEA Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 158 MEA Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 159 GCC Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 160 South Africa Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 161 Rest of MEA Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 162 Women Health Market Company Share, 2022
Figure 163 Abbott Laboratories: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 164 Abbott Laboratories: R&D, 2017-2022 (US$ Million, AGR%)
Figure 165 Bayer AG: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 166 Bayer AG : R&D, 2017-2022 (US$ Million, AGR%)
Figure 167 Bayer AG: Regional Market Shares, 2022
Figure 168 Cardinal Health: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 169 Cardinal Health: Regional Market Shares, 2023
Figure 170 Cooper Surgical, Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 171 Cooper Surgical, Inc.: R&D, 2017-2023 (US$ Million, AGR%)
Figure 172 Cooper Surgical, Inc.: Regional Market Shares, 2023
Figure 173 L. Hoffman-La Roche Ltd.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 174 L. Hoffman-La Roche Ltd.: R&D, 2017-2023 (US$ Million, AGR%)
Figure 175 General Electric Healthcare: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 176 General Electric Healthcare: R&D, 2017-2022 (US$ Million, AGR%)
Figure 177 General Electric Healthcare: Regional Market Shares, 2022
Figure 178 Hologic Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 179 Hologic Inc: R&D, 2017-2023 (US$ Million, AGR%)
Figure 180 Hologic Inc: Regional Market Shares, 2022
Figure 181 Koninklijke Philips N.V: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 182 Koninklijke Philips N.V: R&D, 2017-2022 (US$ Million, AGR%)
Figure 183 Prestige Consumer Healthcare Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 184 Siemens AG: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 185 Siemens AG: R&D, 2017-2023 (US$ Million, AGR%)
Figure 186 Siemens AG: Regional Market Shares, 2023